Daniel (Dani) Bendheim

“On June 25, 2026, in connection with Daniel (Dani) Bendheim's appointment to the role of Chief Executive Officer and President of the Company effective July 1, 2026 (the "Effective Date"), the Compensation Committee of the Board of Directors of Phibro Animal Health Corporation (the "Company") approved (i) the Company's entry into an employment agreement with Mr. D. Bendheim, effective as of the Effective Date (the "Employment Agreement") and (ii) the grant of 300,000 restricted stock units ("RSUs" and, such award, the "Initial RSUs") to Mr. D. Bendheim, pursuant to the Company's 2008 Incentive Plan and the RSU award agreement (the "Award Agreement").”

“On the Effective Date, Daniel (Dani) Bendheim, age 53, the Company's current Executive Vice President, Corporate Strategy, will assume the role of Chief Executive Officer and President of the Company.”